Zeljko Uzelac
Albert Einstein Allee 23
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.
Journal: Neurology
Published: February 23, 2026
Advanced neuroimaging assessment of neurodegenerative dementia syndromes: A framework for comprehensive multimodal FDG-PET, MR-perfusion, and MR-diffusion analysis.
Journal: NeuroImage. Clinical
Published: July 07, 2025
Pain in adult and adolescent patients with 5q-associated Spinal Muscular Atrophy - an often underrated phenomenon.
Journal: Journal of neuromuscular diseases
Published: May 21, 2025
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.
Journal: Orphanet journal of rare diseases
Published: February 23, 2025
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.
Journal: European journal of neurology
Published: December 29, 2024
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.
Journal: Annals of neurology
Published: December 16, 2024
Association of early general anesthesia with outcome in adults with status epilepticus: A propensity-matched observational study.
Journal: Epilepsia
Published: July 25, 2024
Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen - a monocenter observational study.
Journal: Frontiers in neurology
Published: January 18, 2024
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Journal: EClinicalMedicine
Published: November 06, 2023
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.
Journal: The Lancet regional health. Europe
Published: October 24, 2023
Last Updated: 09/26/2026